JP2014169319A5 - - Google Patents

Download PDF

Info

Publication number
JP2014169319A5
JP2014169319A5 JP2014104022A JP2014104022A JP2014169319A5 JP 2014169319 A5 JP2014169319 A5 JP 2014169319A5 JP 2014104022 A JP2014104022 A JP 2014104022A JP 2014104022 A JP2014104022 A JP 2014104022A JP 2014169319 A5 JP2014169319 A5 JP 2014169319A5
Authority
JP
Japan
Prior art keywords
minocycline base
organic solvent
crystalline
peaks
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014104022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014169319A (ja
Filing date
Publication date
Priority claimed from PT103661A external-priority patent/PT103661B/pt
Application filed filed Critical
Publication of JP2014169319A publication Critical patent/JP2014169319A/ja
Publication of JP2014169319A5 publication Critical patent/JP2014169319A5/ja
Pending legal-status Critical Current

Links

JP2014104022A 2007-02-23 2014-05-20 結晶性ミノサイクリン塩基及びその製造方法 Pending JP2014169319A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103661 2007-02-23
PT103661A PT103661B (pt) 2007-02-23 2007-02-23 Processo de preparação de minociclina base cristalina

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009550320A Division JP2010519247A (ja) 2007-02-23 2008-02-22 結晶性ミノサイクリン塩基及びその製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016189162A Division JP2017039742A (ja) 2007-02-23 2016-09-28 結晶性ミノサイクリン塩基及びその製造方法

Publications (2)

Publication Number Publication Date
JP2014169319A JP2014169319A (ja) 2014-09-18
JP2014169319A5 true JP2014169319A5 (enExample) 2015-05-21

Family

ID=39432804

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009550320A Withdrawn JP2010519247A (ja) 2007-02-23 2008-02-22 結晶性ミノサイクリン塩基及びその製造方法
JP2014104022A Pending JP2014169319A (ja) 2007-02-23 2014-05-20 結晶性ミノサイクリン塩基及びその製造方法
JP2016189162A Pending JP2017039742A (ja) 2007-02-23 2016-09-28 結晶性ミノサイクリン塩基及びその製造方法
JP2019059559A Pending JP2019142882A (ja) 2007-02-23 2019-03-27 結晶性ミノサイクリン塩基及びその製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009550320A Withdrawn JP2010519247A (ja) 2007-02-23 2008-02-22 結晶性ミノサイクリン塩基及びその製造方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016189162A Pending JP2017039742A (ja) 2007-02-23 2016-09-28 結晶性ミノサイクリン塩基及びその製造方法
JP2019059559A Pending JP2019142882A (ja) 2007-02-23 2019-03-27 結晶性ミノサイクリン塩基及びその製造方法

Country Status (20)

Country Link
US (2) US8258327B2 (enExample)
EP (1) EP2125705B1 (enExample)
JP (4) JP2010519247A (enExample)
KR (1) KR101391132B1 (enExample)
CN (1) CN101679218B (enExample)
AU (1) AU2008217619B2 (enExample)
BR (2) BR122021000846B1 (enExample)
CA (2) CA2722496C (enExample)
DK (1) DK2125705T3 (enExample)
ES (1) ES2610434T3 (enExample)
HU (1) HUE033030T2 (enExample)
IL (1) IL200544A0 (enExample)
MX (2) MX2009008980A (enExample)
NO (1) NO20092960L (enExample)
NZ (1) NZ579626A (enExample)
PL (1) PL2125705T3 (enExample)
PT (1) PT103661B (enExample)
RU (2) RU2485095C2 (enExample)
WO (1) WO2008102161A2 (enExample)
ZA (1) ZA200906517B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
PT104644B (pt) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
PT106063B (pt) 2011-12-19 2017-05-30 Inst Superior Tecnico Minociclina cristalina termorresistente produzida por recristalização com dióxido de carbono
CN104151186B (zh) * 2014-08-11 2016-06-15 重庆福安药业(集团)股份有限公司 替加环素杂质的立体选择性制备方法
PT108223B (pt) * 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
AU2016235237B2 (en) 2015-03-23 2021-03-11 BioPharmX, Inc. Pharmaceutical tetracycline composition for dermatological use
WO2017097891A1 (en) * 2015-12-10 2017-06-15 Sandoz Ag Crystalline eravacycline
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
CN113557008A (zh) 2018-10-29 2021-10-26 弗劳恩霍夫应用研究促进协会 具有持续活性的四环素类络合物
WO2021191273A1 (en) 2020-03-24 2021-09-30 Hovione Scientia Limited Compositions for use in treating meibomian gland dysfunction
US20220062308A1 (en) 2020-08-27 2022-03-03 Hovione Scientia Limited Methods and compositions for treating rosacea
CN117105812B (zh) * 2023-08-16 2025-09-26 常州市第四制药厂有限公司 一种米诺环素无菌软膏剂及制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US299111A (en) * 1884-05-27 Process of and apparatus
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3526629A (en) * 1968-04-02 1970-09-01 American Cyanamid Co Beta-hydroxyethylpiperazinocarboxymethyl - 7 - dimethylamino - 6 - deoxy-6-demethyltetracycline
JPS5245716B1 (enExample) * 1970-07-10 1977-11-17
NL158172B (nl) * 1972-09-18 1978-10-16 Farmaceutici Italia Werkwijze voor het bereiden van tetracyclinederivaten met een substituent op de 7-plaats.
CN85101404A (zh) * 1985-05-16 1987-01-17 帝人株式会社 头孢菌素衍生物的生产过程
JPH0737433B2 (ja) 1987-06-11 1995-04-26 協和醗酵工業株式会社 7−アミノ−6−デメチル−6−デオキシテトラサイクリンの製造法
US4918208A (en) * 1987-07-28 1990-04-17 Nippon Kayaku Kabushiki Kaisha Process for producing 7-dimethylamino-6-demethyl-6-deoxytetracycline
US5202449A (en) * 1987-07-28 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline
JPH04235188A (ja) * 1990-06-19 1992-08-24 Takeda Chem Ind Ltd ペネム化合物の結晶、その製造方法および抗菌剤
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja) * 1993-06-07 2005-02-23 ビーエーエスエフ アクチェンゲゼルシャフト 結晶質l−アスコルビン酸−2−燐酸エステルマグネシウム塩の製造法
BR9609872A (pt) * 1995-07-17 1999-03-23 Warner Lambert Co Hemi sal de cálcio de ácido (R-(R*R*)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino
NZ504834A (en) 1997-12-22 2001-12-21 Schering Corp Tricyclic amide molecular dispersion composition with enhanced bioavailability
AU1405600A (en) * 1998-12-01 2000-06-19 Atropos Limited A medical device comprising an evertable sleeve
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina

Similar Documents

Publication Publication Date Title
RU2009135403A (ru) Кристаллическое основание миноциклина и способы его получения
PE20120989A1 (es) Sales de disacarina, acido difumarico, acido d-1-hidroxi-2-naftoico y monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il) metil) fenil) acetato de 4-(dimetilamino) butilo
WO2015145415A3 (en) Ibrutinib solid forms and production process therefor
JP2013199502A5 (enExample)
JP2011126894A5 (enExample)
MX378717B (es) Acidos carboxilicos heterociclicos como activadores de guanilato ciclasa soluble.
RU2016146119A (ru) Новый кристалл тетрациклического соединения
JP2018505199A5 (enExample)
AR080275A1 (es) Formas solidas de un derivado de n-( fenilmetil) propanamida y procedimientos de preparacion
WO2015008218A3 (en) Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
RU2016100236A (ru) Способ получения исходного табачного материала
MX376283B (es) Compuestos de imidazopiridazina.
WO2015038267A3 (en) Graphene synthesis by suppressing evaporative substrate loss during low pressure chemical vapor deposition
CO2020006258A2 (es) Proceso para preparar partículas de isoxazolina de gran tamaño
MX367376B (es) Formulas cristalinas de grapiprant.
JP2015516425A5 (enExample)
WO2016038628A3 (en) A process for preparing olodaterol and intermediates thereof
PH12016500850B1 (en) Co-crystal and method for producing same
JP2016510767A5 (enExample)
AR087344A1 (es) Formas polimorficas del acido 5-(3,3-dimetil-but-1-inil)-3-[(trans-4-hidroxi-ciclohexil)-(trans-4-metil-ciclohexancarbonil)-amino]-tiofen-2-carboxilico y su uso en el tratamiento de la hepatitis c
RU2019106531A (ru) Кристалл соли производного хиназолина
RU2016144187A (ru) Твердые формы фармацевтически активного соединения
JP2016516014A5 (enExample)
WO2013065070A8 (en) Amorphous form of cabazitaxel and process for its preparation
JP2018502165A5 (enExample)